Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Epidemiology and biology of physical activity and cancer recurrence.

Friedenreich CM, Shaw E, Neilson HK, Brenner DR.

J Mol Med (Berl). 2017 Jun 15. doi: 10.1007/s00109-017-1558-9. [Epub ahead of print] Review.

2.

Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies.

Kim NH, Suh JY, Park JH, Park DI, Cho YK, Sohn CI, Choi K, Jung YS.

Yonsei Med J. 2017 Mar;58(2):347-354. doi: 10.3349/ymj.2017.58.2.347.

3.

Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy: A single-center experience in Korea.

Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS.

Medicine (Baltimore). 2016 Aug;95(32):e4454. doi: 10.1097/MD.0000000000004454.

4.

Awareness of Lifestyle and Colorectal Cancer Risk: Findings from the BeWEL Study.

Anderson AS, Caswell S, Macleod M, Craigie AM, Stead M, Steele RJ; BeWEL Team.

Biomed Res Int. 2015;2015:871613. doi: 10.1155/2015/871613. Epub 2015 Oct 4.

5.

Why are some people more successful at lifestyle change than others? Factors associated with successful weight loss in the BeWEL randomised controlled trial of adults at risk of colorectal cancer.

Stead M, Craigie AM, Macleod M, McKell J, Caswell S, Steele RJ, Anderson AS.

Int J Behav Nutr Phys Act. 2015 Jun 26;12:87. doi: 10.1186/s12966-015-0240-2.

6.

Racial differences in obesity measures and risk of colorectal adenomas in a large screening population.

Murphy CC, Martin CF, Sandler RS.

Nutr Cancer. 2015;67(1):98-104. doi: 10.1080/01635581.2015.976316. Epub 2014 Nov 25.

7.

The risk of colonic adenomas and colonic cancer in obesity.

Laiyemo AO.

Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):655-63. doi: 10.1016/j.bpg.2014.07.007. Epub 2014 Jul 10. Review.

8.

Sedentary behavior is associated with colorectal adenoma recurrence in men.

Molmenti CL, Hibler EA, Ashbeck EL, Thomson CA, Garcia DO, Roe D, Harris RB, Lance P, Cisneroz M, Martinez ME, Thompson PA, Jacobs ET.

Cancer Causes Control. 2014 Oct;25(10):1387-95. doi: 10.1007/s10552-014-0444-9. Epub 2014 Jul 25.

9.

The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial.

Anderson AS, Craigie AM, Caswell S, Treweek S, Stead M, Macleod M, Daly F, Belch J, Rodger J, Kirk A, Ludbrook A, Rauchhaus P, Norwood P, Thompson J, Wardle J, Steele RJ.

BMJ. 2014 Mar 7;348:g1823. doi: 10.1136/bmj.g1823.

10.

Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Kitahara CM, Berndt SI, de González AB, Coleman HG, Schoen RE, Hayes RB, Huang WY.

J Clin Oncol. 2013 Jul 1;31(19):2450-9. doi: 10.1200/JCO.2012.48.4691. Epub 2013 May 28.

11.

Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Burnett-Hartman AN, Passarelli MN, Adams SV, Upton MP, Zhu LC, Potter JD, Newcomb PA.

Am J Epidemiol. 2013 Apr 1;177(7):625-37. doi: 10.1093/aje/kws282. Epub 2013 Mar 3.

12.

Obesity, weight change, and risk of adenoma recurrence: a prospective trial.

Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ.

Endoscopy. 2012 Sep;44(9):813-8. doi: 10.1055/s-0032-1309837. Epub 2012 Aug 27.

13.

Detailed protocol for the lifestyle intervention in the BeWEL randomised controlled trial of weight loss in adults who have had a colorectal adenoma.

Caswell S, Craigie AM, Wardle J, Stead M, Anderson A.

BMJ Open. 2012 May 25;2(3). pii: e001276. doi: 10.1136/bmjopen-2012-001276. Print 2012.

14.

Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice.

Lance P, Thompson PA.

J Carcinog. 2011;10:11. doi: 10.4103/1477-3163.79674. Epub 2011 Apr 16. No abstract available.

15.

Likelihood of missed and recurrent adenomas in the proximal versus the distal colon.

Laiyemo AO, Doubeni C, Sanderson AK 2nd, Pinsky PF, Badurdeen DS, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Schatzkin A, Cross AJ.

Gastrointest Endosc. 2011 Aug;74(2):253-61. doi: 10.1016/j.gie.2011.02.023. Epub 2011 May 6.

16.

Study protocol for BeWEL: the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas.

Craigie AM, Caswell S, Paterson C, Treweek S, Belch JJ, Daly F, Rodger J, Thompson J, Kirk A, Ludbrook A, Stead M, Wardle J, Steele RJ, Anderson AS.

BMC Public Health. 2011 Mar 25;11:184. doi: 10.1186/1471-2458-11-184.

17.

Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps.

Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Burnett-Hartman A, Wurscher MA, Zheng Y, Mandelson MT.

Growth Horm IGF Res. 2010 Aug;20(4):305-9. doi: 10.1016/j.ghir.2010.04.001. Epub 2010 May 26.

18.

Cancer-specific beliefs and survival in nonmetastatic colorectal cancer patients.

Soler-Vilá H, Dubrow R, Franco VI, Saathoff AK, Kasl SV, Jones BA.

Cancer. 2009 Sep 15;115(18 Suppl):4270-82. doi: 10.1002/cncr.24583.

19.

Adiposity in relation to colorectal adenomas and hyperplastic polyps in women.

Leitzmann MF, Flood A, Ferrucci LM, Schoenfeld P, Cash B, Schatzkin A, Cross AJ.

Cancer Causes Control. 2009 Oct;20(8):1497-507. doi: 10.1007/s10552-009-9346-7. Epub 2009 Apr 22.

20.

Components of metabolic syndrome and metachronous colorectal neoplasia.

Ashbeck EL, Jacobs ET, Martínez ME, Gerner EW, Lance P, Thompson PA.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1134-43. doi: 10.1158/1055-9965.EPI-08-1015. Epub 2009 Mar 24.

Supplemental Content

Support Center